Genetic Disease

A new integrative model demonstrated “strong predictive performance” in identifying future risk for Crohn’s disease development among healthy first-degree relatives of patients with CD, according to a researcher.

Treatment for Helicobacter pylori infection was associated with reduced risk for gastric cancer among patients with a high genetic risk, suggesting that chemoprevention should be personalized to genetic risk, according to data.

A common cardiac amyloidosis-causing gene believed to be present in around 3% of the Black U.S. population is associated with increased risk for HF hospitalization and death, which increases with age, a speaker reported.

Alexis Thompson, MD, MPH, is an optimist.

Recently, there have been a number of cases in which high-profile athletes have had sudden cardiac arrest due to a variety of causes.

It is not uncommon for endocrinologists to treat adults with both diabetes and thyroid disease.

A Bay Area pharmaceutical firm has announced positive data from a phase 3 clinical trial evaluating Chenodal tablets to treat adults with cerebrotendinous xanthomatosis, an autosomal, recessive, progressive genetic disorder.

Genetic variants located near KLF5 and SOX9 may be associated with a higher risk for hidradenitis suppurativa, according to a study.

An Australian general practitioner-led screening and care program for heterozygous familial hypercholesterolemia was projected to be cost-effective with significant return on investment vs. standard care, researchers reported.

Genetic variants associated with CVD found incidentally during testing should be interpreted with caution using a framework that includes a multidisciplinary team of experts, according to a new scientific statement.